
Peniel M. Gumedzoe
Examiner (ID: 86, Phone: (571)270-3041 , Office: P/2899 )
| Most Active Art Unit | 2899 |
| Art Unit(s) | 2891, 2899 |
| Total Applications | 1592 |
| Issued Applications | 1301 |
| Pending Applications | 82 |
| Abandoned Applications | 248 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4026378
[patent_doc_number] => 05883136
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth'
[patent_app_type] => 1
[patent_app_number] => 8/478411
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 8149
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 477
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/883/05883136.pdf
[firstpage_image] =>[orig_patent_app_number] => 478411
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/478411 | Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth | Jun 6, 1995 | Issued |
Array
(
[id] => 3984344
[patent_doc_number] => 05861431
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Incontinence treatment'
[patent_app_type] => 1
[patent_app_number] => 8/477474
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 3916
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861431.pdf
[firstpage_image] =>[orig_patent_app_number] => 477474
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477474 | Incontinence treatment | Jun 6, 1995 | Issued |
| 08/485935 | METHOD TO TREAT CARDIOFIBROSIS WITH A COMBINATION OF AN ANGIOTENSIN II ANTAGONIST AND SPIRONOLACTONE | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4025853
[patent_doc_number] => 05883103
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-16
[patent_title] => 'Oral acyclovir delivery'
[patent_app_type] => 1
[patent_app_number] => 8/475036
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8002
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/883/05883103.pdf
[firstpage_image] =>[orig_patent_app_number] => 475036
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/475036 | Oral acyclovir delivery | Jun 6, 1995 | Issued |
Array
(
[id] => 3657737
[patent_doc_number] => 05658900
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Application of carbamazepine and oxcarbazepine in the treatment of Parkinson\'s disease and parkinsonian syndromes'
[patent_app_type] => 1
[patent_app_number] => 8/446735
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1257
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658900.pdf
[firstpage_image] =>[orig_patent_app_number] => 446735
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446735 | Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and parkinsonian syndromes | Jun 5, 1995 | Issued |
Array
(
[id] => 3698548
[patent_doc_number] => 05677313
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Antipsychotic method'
[patent_app_type] => 1
[patent_app_number] => 8/462931
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20286
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 693
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677313.pdf
[firstpage_image] =>[orig_patent_app_number] => 462931
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462931 | Antipsychotic method | Jun 4, 1995 | Issued |
Array
(
[id] => 3649555
[patent_doc_number] => 05637765
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Process for the preparation of fluorinated benzoic acids'
[patent_app_type] => 1
[patent_app_number] => 8/462235
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6797
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637765.pdf
[firstpage_image] =>[orig_patent_app_number] => 462235
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462235 | Process for the preparation of fluorinated benzoic acids | Jun 4, 1995 | Issued |
Array
(
[id] => 3694431
[patent_doc_number] => 05679686
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'Antipsychotic method'
[patent_app_type] => 1
[patent_app_number] => 8/465215
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20293
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 693
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679686.pdf
[firstpage_image] =>[orig_patent_app_number] => 465215
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465215 | Antipsychotic method | Jun 4, 1995 | Issued |
Array
(
[id] => 4048707
[patent_doc_number] => 05968926
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Antipsychotic method'
[patent_app_type] => 1
[patent_app_number] => 8/463615
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20070
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 723
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/968/05968926.pdf
[firstpage_image] =>[orig_patent_app_number] => 463615
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463615 | Antipsychotic method | Jun 4, 1995 | Issued |
Array
(
[id] => 4404572
[patent_doc_number] => 06228383
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Use of fatty acid esters as bioadhesive substances'
[patent_app_type] => 1
[patent_app_number] => 8/462222
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 19246
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228383.pdf
[firstpage_image] =>[orig_patent_app_number] => 462222
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462222 | Use of fatty acid esters as bioadhesive substances | Jun 4, 1995 | Issued |
Array
(
[id] => 3732914
[patent_doc_number] => 05665762
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'Decontaminating clinical samples'
[patent_app_type] => 1
[patent_app_number] => 8/462954
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 35
[patent_no_of_words] => 18947
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665762.pdf
[firstpage_image] =>[orig_patent_app_number] => 462954
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462954 | Decontaminating clinical samples | Jun 4, 1995 | Issued |
Array
(
[id] => 3843375
[patent_doc_number] => 05708030
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Substituted kynurenines and process for their preparation'
[patent_app_type] => 1
[patent_app_number] => 8/463895
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4588
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/708/05708030.pdf
[firstpage_image] =>[orig_patent_app_number] => 463895
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463895 | Substituted kynurenines and process for their preparation | Jun 4, 1995 | Issued |
Array
(
[id] => 3519766
[patent_doc_number] => 05529997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace'
[patent_app_type] => 1
[patent_app_number] => 8/459208
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16861
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/529/05529997.pdf
[firstpage_image] =>[orig_patent_app_number] => 459208
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459208 | Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace | Jun 1, 1995 | Issued |
Array
(
[id] => 3777653
[patent_doc_number] => 05779357
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'Method and apparatus for the preparation of a medical solution'
[patent_app_type] => 1
[patent_app_number] => 8/455319
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2735
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/779/05779357.pdf
[firstpage_image] =>[orig_patent_app_number] => 455319
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455319 | Method and apparatus for the preparation of a medical solution | May 30, 1995 | Issued |
Array
(
[id] => 4238096
[patent_doc_number] => 06143782
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-07
[patent_title] => 'Anti-inflammatory and anti-asthma treatment with reduced side effects'
[patent_app_type] => 1
[patent_app_number] => 8/456274
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7292
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/143/06143782.pdf
[firstpage_image] =>[orig_patent_app_number] => 456274
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456274 | Anti-inflammatory and anti-asthma treatment with reduced side effects | May 30, 1995 | Issued |
Array
(
[id] => 3806298
[patent_doc_number] => 05830907
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Application of riluzole in the treatment of neurological lesions associated with trauma'
[patent_app_type] => 1
[patent_app_number] => 8/424529
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1790
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830907.pdf
[firstpage_image] =>[orig_patent_app_number] => 424529
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/424529 | Application of riluzole in the treatment of neurological lesions associated with trauma | May 29, 1995 | Issued |
Array
(
[id] => 3762393
[patent_doc_number] => 05852036
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'Method for treating anxiety'
[patent_app_type] => 1
[patent_app_number] => 8/448278
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6288
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/852/05852036.pdf
[firstpage_image] =>[orig_patent_app_number] => 448278
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/448278 | Method for treating anxiety | May 22, 1995 | Issued |
Array
(
[id] => 3688424
[patent_doc_number] => 05643911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia'
[patent_app_type] => 1
[patent_app_number] => 8/441743
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3373
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643911.pdf
[firstpage_image] =>[orig_patent_app_number] => 441743
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441743 | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia | May 15, 1995 | Issued |
Array
(
[id] => 3519995
[patent_doc_number] => 05530013
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Venlafaxine in the inducement of cognition enhancement'
[patent_app_type] => 1
[patent_app_number] => 8/442546
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2907
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530013.pdf
[firstpage_image] =>[orig_patent_app_number] => 442546
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442546 | Venlafaxine in the inducement of cognition enhancement | May 15, 1995 | Issued |
| 08/440337 | AGENT FOR PREVENTION OR ALLEVIATION OF ALLERGY SYMPTOMS | May 11, 1995 | Abandoned |